Professor Tales said of the project: We expect the outcome of this research study to increase our understanding of vascularrelated mild cognitive impairment and vascular dementia and to have a direct, positive influence on the development of reallife and clinically-relevant tests of brain function, such as those used for early diagnosis and for ...
After several infections with different strains of the virus, children acquire immunity to rotavirus. Babies and toddlers between 6-24 months of age are at greatest risk for developing severe disease from rotavirus infection. Adults sometimes become infected, but the resulting illness is usually mild.
1 Oral rotavirus vaccination protects most young children against severe dehydrating rotavirus gastroenteritis that most commonly occurs between 3 and 35 months of age. 2  It does not provide lifetime protection. 3  Rotarix is a live, monovalent, human attenuated vaccine given in 2 doses (one course) at 2 and 4 months of age. In clinical trials vaccination reduced the rate of severe rotavirus gastroenteritis by 85% to 98%, and the rate of hospitalisation for gastroenteritis of any cause by 42% to 59%. 2  1,2. 3  Safety and efficacy of either vaccine has not been established in infants under 6 weeks of age.